Meeder Asset Management Inc Coherus Bio Sciences, Inc. Transaction History

Meeder Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.17 - $13.87 $50 - $97	7 Added 3.65%	199 $2,000
Q2 2022 Aug 08, 2022	BUY	$5.86 - $13.23 $521 - $1,177	89 Added 86.41%	192 $1,000
Q1 2022 May 10, 2022	BUY	$10.92 - $16.41 $1,124 - $1,690	103 New	103 $1,000
Q4 2021 Feb 11, 2022	SELL	$15.81 - $18.99 $1,185 - $1,424	-75 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$12.68 - $17.79 $951 - $1,334	75 New	75 $1,000
Q2 2021 Aug 09, 2021	SELL	$12.95 - $15.41 $64 - $77	-5 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$17.41 - $19.89 $73,957 - $84,492	-4,248 Reduced 99.88%	5 $0
Q2 2020 Aug 11, 2020	SELL	$14.43 - $19.16 $39,134 - $51,961	-2,712 Reduced 38.94%	4,253 $77,000
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $54,802 - $105,800	4,696 Added 206.96%	6,965 $114,000
Q4 2019 Feb 13, 2020	BUY	$16.33 - $21.37 $29,312 - $38,359	1,795 Added 378.69%	2,269 $40,000
Q3 2019 Oct 17, 2019	SELL	$16.3 - $23.37 $265,005 - $379,949	-16,258 Reduced 97.17%	474 $10,000
Q2 2019 Aug 05, 2019	BUY	$13.1 - $22.1 $219,189 - $369,777	16,732 New	16,732 $369,000
Q1 2018 May 03, 2018	SELL	$9.1 - $13.7 $900 - $1,356	-99 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$8.35 - $14.4 $826 - $1,425	99	99 $1,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $115M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.